University of Wisconsin
Madison, Wisconsin, 53792, United States
NCT Number: NCT03526458
The primary objective of this study is to compare the time to acceptable stone fragmentation during clinical use of the holmium laser when using energy settings 0.2J vs 0.8J. The hypothesis is that holmium laser energy settings 0.8J will require less time than lower energy settings 0.2J for fragmenting urinary stones. The clinical practice is to treat urinary stones until the stone is reduced to fragments ≤ 2 mm in size. This is determined by using the laser fiber which is 273 microns to visually estimate the size of the resultant fragments as described by Patel et al, J Endo 2014. Investigators will standardize the effect of stone size by creating a ratio of stone size to treatment time. In this study, the frequency is set at 15Hz. Thus, the study contains two arms: 0.2J&15Hz, and 0.8J&15Hz. Patients will be randomized into the two groups by the ratio of 1:1.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Madison, Wisconsin, 53792, United States
The only interventions imposed on subjects as a result of this study are (1) pre-procedural randomization to laser lithotripsy with either 0.2J or 0.8J energy setting, and (2) the use of patient information in describing results. All the other activities are part of the routine clinical practice in the department. Participation in the study will not alter the patients' preoperative, or postoperative care. During surgery, patients' stones will be treated in accordance with the routine clinical practice of fragmenting stones into small pieces (<2 mm). All patients enrolled will undergo routine post-operative follow up including clinic appointments and imaging evaluation. Any complications will be recorded, reported, and treated appropriately. A fixed frequency will be used (15Hz). Thus, the study contains two arms: 0.2J&15Hz, and 0.8J&15Hz. Patients will be randomized into the two groups by the ratio of 1:1. A total of 1 clinic visit (i.e., the stone surgery, approximately 5-6 hours, depending on the duration of the surgery) is needed for this study.
The study procedures are:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment of urolithiasis is commonly done using the holmium:YAG laser as this has been shown to be a safe and effective method of treating a wide variety of stones and is currently considered the standard of care (AUA Guideline Panel on the Surgical Management of Stones)
Time frame: up to 6 hours
The time to fragment a stone into small pieces (≤2 mm, which is our current institutional practice)
Time frame: up to 6 hours
Time frame: Retrospective review of health chart at Baseline
Pre-operative stone size (on pre-operative CT) will be reported in millimeters.
Time frame: up to 6 hours
Urinary stone location will be classified as renal or ureter.
Time frame: up to 6 hours
Time frame: up to 6 hours
Time frame: up to 6 hours
Size of fragments created will be assessed using the laser fiber size as a comparison.
University of Wisconsin, Madison
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04594161
Acute Kidney Injury, Bites and Stings
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT03567421
Calculi, Female Urogenital Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT07607626
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
View Trial DetailsNCT05183269
Agnosia, Calculi
Ghent, Oost-Vlaanderen, Belgium
View Trial Details